Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

Amgen has announced a reduction in the price of its cholesterol medication, Repatha, following a call from former President Trump for lower drug prices. This move is significant as it reflects a growing trend among pharmaceutical companies to make medications more affordable for patients. The launch of AmgenNow, a direct-to-patient program, aims to enhance access to this vital treatment, potentially benefiting many individuals struggling with high cholesterol.